Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update
      Biotech

      Palatin Reports Fiscal First Quarter 2027 Financial Results and Provides Business Update

      November 18, 2026
      Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger
      Biotech

      Pulmatrix Announces Third Quarter 2026 Financial Results and Progress on Merger

      November 18, 2026
      Planet Green Holdings Acquires Registered Lactoferrin Immunity Chewable Tablet, Accelerating Its Entry into Growing Immune-Health Market
      Biotech

      Planet Green Holdings Acquires Registered Lactoferrin Immunity Chewable Tablet, Accelerating Its Entry into Growing Immune-Health Market

      November 18, 2026
      MetaVia Announces Completion of Last Patient Visit in Extended 24-Week Phase 1 Part 3A Study of DA-1726
      Biotech

      MetaVia Announces Completion of Last Patient Visit in Extended 24-Week Phase 1 Part 3A Study of DA-1726

      November 18, 2026
      Viatris Completes Acquisition of Pacira BioSciences
      Biotech

      Viatris Completes Acquisition of Pacira BioSciences

      November 17, 2026
      RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor “What This Means” Segment
      Biotech

      RedHill Biopharma (Nasdaq: RDHL) Highlights Strategic Transformation and Expanded Commercial Growth Strategy in Virtual Investor “What This Means” Segment

      November 17, 2026
      Inhibrx Announces Updated Clinical Data for Ozekibart (INBRX-109) in Ewing Sarcoma
      Biotech

      Inhibrx Announces Updated Clinical Data for Ozekibart (INBRX-109) in Ewing Sarcoma

      November 17, 2026
      Harbour BioMed’s Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company
      Biotech

      Harbour BioMed’s Partner Spruce Biosciences Separates CRHX-101 Program into Adrenyx Biosciences, Advancing Development of Harbour BioMed-Originated Antibody through a Standalone Company

      November 17, 2026
      Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026
      Biotech

      Burning Rock Announces 2026 Annual General Meeting to be Held on December 22, 2026

      November 17, 2026
      Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development
      Biotech

      Cancer Research UK and Dewpoint Therapeutics partner to advance potential first-in-class MYC condensate modulator into clinical development

      November 17, 2026
      1 2 3 … 175 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026